Remdesivir administration for Japanese COVID-19 patients undergoing maintenance hemodialysis: a retrospective observation with six case reports.

Jun ItoMoritsugu KimuraTomoyuki ToyaKonomi IsozumiAtsuro KawajiYudai IsozakiMasafumi Fukagawa

Published in: Renal replacement therapy (2022)

We were able to administer remdesivir to six Japanese patients with moderate COVID-19 on hemodialysis safely. It is expected that the safe use of remdesivir will bring an increase in treatment options for moderate cases of COVID-19 in dialysis patients as well as subsequent improvement in treatment outcomes. However, to confirm the efficacy and safety of such use, further careful observation in more cases is required.

Keyphrases

end stage renal disease
chronic kidney disease
coronavirus disease
peritoneal dialysis
sars cov
patients undergoing
high intensity
newly diagnosed
ejection fraction
respiratory syndrome coronavirus
case report
prognostic factors
patient reported outcomes